Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,153–4,160 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
UroGen Pharma Ltd. UGN-103 - (UTOPIA) Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer NDA Filing Ongoing Intravesical Oncology
UroGen Pharma Ltd. UGN-102 - (ATLAS) Non-Muscle-Invasive Bladder Cancer NDA Filing Ongoing Intravesical Oncology
UroGen Pharma Ltd. UGN-102 - (home instillation study) Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) Phase 3 Ongoing Intravesical Oncology
UroGen Pharma Ltd. UGN-102 - (OPTIMA II) Non-Muscle-Invasive Bladder Cancer Phase 2b Data Released Intravesical Oncology
UroGen Pharma Ltd. RTGel in combination with BOTOX Overactive Bladder (OAB) Phase 2 Trial Discontinued Intravesical N/A
Valneva SE IXCHIQ (VLA1553-303) Chikungunya vaccine BLA Filing Withdrawn Subcutaneous N/A
Valneva SE IXCHIQ (VLA1553-303) Chikungunya vaccine BLA Filing Withdrawn Subcutaneous N/A
Valneva SE VLA1553-321 - (Adolescents trial) Chikungunya Vaccine for adolecents sNDA Filing Data Released Subcutaneous N/A